Category archive
Sarvada research, workflows, and commentary focused on market & trends.
Archive
130 published articles
Topic
Market & Trends
Latest
August 13, 2026
Browse by topic
130 articles
Market & Trends - July 12, 2026 - 10 min read
Converting an agency into a licensed broking firm is a balance-sheet decision, not a career step. What the door costs, whether the book travels, how the revenue bridge actually works, and how long the payback really takes.
By Sarvada Editorial Team
Market & Trends - July 12, 2026 - 10 min read
A health book behaves like the opposite of a motor book. The ticket is larger, the client is far harder to move, and the value accrues rather than resets. The price of that is servicing, and an age-banded renewal conversation that gets harder every year rather than easier.
By Sarvada Editorial Team
Market & Trends - July 11, 2026 - 10 min read
Motor is where almost every point of sales person starts, because it is the one product on the permitted list where demand arrives pre-formed. It is also the channel's treadmill: thin rupees per policy, a servicing cost that does not shrink with the premium, and a twelve-month cycle that re-opens every decision you already won.
By Sarvada Editorial Team
Market & Trends - July 9, 2026 - 10 min read
How employee-benefits brokers in India earn on group health and allied benefits in 2026: commission versus fee versus hybrid models, add-on and wellness income, the squeeze from insurer loss ratios, and why documented servicing depth is becoming the basis for defending remuneration as IRDAI moves toward effort-based commission rules.
By Sarvada Editorial Team
Market & Trends - July 9, 2026 - 10 min read
A working playbook for small and regional Indian broking firms facing commission reform and rising compliance cost: niche specialisation, servicing depth as a moat under effort-based pay, shared back-office utilities, and a clear-eyed view of when to join a network or sell.
By Sarvada Editorial Team
Market & Trends - July 9, 2026 - 8 min read
As commission reform and EOM discipline squeeze commodity-line brokerage, specialty lines are holding their economics. The placement effort, limited panels, and wording negotiation behind that resilience, and what it means for broker product strategy in 2026.
By Sarvada Editorial Team
Market & Trends - July 9, 2026 - 10 min read
Rising employee dishonesty, social-engineering fraud and third-party crime are pulling commercial crime insurance India and fidelity guarantee cover onto the boardroom agenda in 2026, and the IRDAI fraud monitoring framework has sharpened the scrutiny for buyers and underwriters alike.
By Sarvada Editorial Team
Market & Trends - July 8, 2026 - 10 min read
The unit economics of group health broking in 2026: why premium inflation no longer translates into brokerage growth, how claims ratios above 100 percent turn insurers against distribution cost, what endorsement volumes, claims desks, and NHCX workflows actually cost, and the portfolio strategies that keep an EB book profitable.
By Sarvada Editorial Team
Market & Trends - July 8, 2026 - 9 min read
The 2026 commission-reform pipeline is repricing Indian broker M&A. How buyers now grade revenue quality across upfront, renewal, and fee income, the diligence questions that decide multiples, and earn-out structures that share regulatory risk between buyer and seller.
By Sarvada Editorial Team
Market & Trends - July 8, 2026 - 9 min read
IRDAI's reported commission overhaul targets passive bank-channel selling and proposes paying more for advisory, documentation, and claims servicing. What that means for banca economics, and how brokers can win corporate and SME accounts currently sold through bank channels.
By Sarvada Editorial Team
Market & Trends - July 8, 2026 - 9 min read
Marsh's 2026 report puts India at 33% of Asia's transactional-risk claim notifications, with 92% tied to PE-backed deals. Here is what drives W&I, tax and contingent-liability adoption, and where capacity and pricing now sit.
By Sarvada Editorial Team
Market & Trends - July 7, 2026 - 10 min read
With IRDAI preparing a commission-rules overhaul and a consultation paper expected by end July 2026, Indian brokers are re-examining fee-based advisory. What the IRDAI (Insurance Brokers) Regulations, 2018 permit, how to price retainers and project work, and where mid-market and large corporate clients actually accept fees.
By Sarvada Editorial Team
Market & Trends - July 7, 2026 - 9 min read
The Air India AI171 crash produced an estimated $475m in claims against a sector that collects a fraction of that in annual premium, hardening hull, war and liability rates and tightening reinsurance terms at the 2026 renewal.
By Sarvada Editorial Team
Market & Trends - July 6, 2026 - 8 min read
Corporate agents, brokers, insurance marketing firms, and web aggregators sell the same policies under different remuneration economics. How the arbitrage works, why IRDAI's planned 2026 commission overhaul targets it, and what brokers should argue in their consultation responses.
By Sarvada Editorial Team
Market & Trends - July 6, 2026 - 10 min read
IRDAI is weighing a shift from upfront to staggered trail commissions paid over the policy life. What that would do to broker working capital, renewal-book value, hiring plans, and financing needs, with a worked cash-flow model for a mid-size Indian broking firm.
By Sarvada Editorial Team
Market & Trends - July 6, 2026 - 9 min read
As single hyperscale campuses in India approach insurable values that exhaust a whole market's property appetite, brokers face a capacity crunch driven by aggregation, thin reinsurance budgets and a global coverage ceiling. Here is how placement and pricing are changing, and what buyers do when limits run out.
By Sarvada Editorial Team
Market & Trends - July 5, 2026 - 9 min read
Since IRDAI removed product-wise commission caps in 2023, commercial brokerage rates are set by insurer board policies inside the EOM envelope. Indicative brokerage ranges by line, why insurer policies differ, and how broking firms should benchmark and negotiate in 2026.
By Sarvada Editorial Team
Market & Trends - July 5, 2026 - 10 min read
GCCs took 38% of top-seven-city office leasing in 2025, and every square foot pulls a specific insurance programme with it. This is the market read on the property, technology E&O, cyber, D&O and people covers behind India's capability-centre build-out, and where the broking opportunity sits.
By Sarvada Editorial Team
Market & Trends - July 2, 2026 - 6 min read
Record public capital spending, PLI-driven factory build-outs and a logistics-park pipeline are creating structural demand for Contractors' All Risks, Erection All Risks, project cargo and delay-in-startup cover. This market-trends view sets out for engineering underwriters and brokers where capacity, ALOP and DSU appetite and rate discipline will be tested as the project pipeline lands.
By Sarvada Editorial Team
Market & Trends - July 2, 2026 - 5 min read
A scaled-up Maritime Development Fund, a richer shipbuilding subsidy and infrastructure status for ships are seeding a wave of yard construction and tonnage growth. This market-trends read sets out for marine underwriters and brokers the builders'-risk, hull and ship-repair liability demand this creates, and where domestic capacity must be backstopped by reinsurance.
By Sarvada Editorial Team
Market & Trends - July 2, 2026 - 5 min read
With the repo rate at 5.25% and the 10-year G-sec near 6.7%, the era of fat investment income subsidising soft underwriting is fading. This market-trends analysis explains how lower reinvestment yields, combined with combined ratios near 100, push insurers toward genuine rate discipline, and what that means for commercial renewals through 2026.
By Sarvada Editorial Team
Market & Trends - July 2, 2026 - 5 min read
The latest PMFBY reform package layers remote-sensing yield estimation, automated claims and a technology fund onto India's crop-insurance scheme, while penalising insurers for delays. This market-trends read explains for agri-insurance underwriters and brokers how transparency, escrow funding and tech infusion are changing the economics of the line through 2026.
By Sarvada Editorial Team
Market & Trends - July 1, 2026 - 6 min read
Health is now the largest general-insurance line in India, but corporate group mediclaim is repricing hard. Medical inflation running near 14% and claims ratios past 90% are forcing insurers to push rate, and the squeeze is reshaping how 2026 renewals are rated and structured. This post is a market read for brokers placing employee-benefit programmes: the inflation and loss-ratio drivers, the levers insurers are pulling, and how to take an employer through a hardening renewal.
By Sarvada Editorial Team
Market & Trends - July 1, 2026 - 6 min read
After the 2021 boom, Indian insurtech funding has collapsed and consolidation is setting in. With investment down sharply and capital flowing only to a few late-stage names, the survivors-versus-shutdowns dynamic now matters to any broker leaning on insurtech rails, MGA platforms or embedded-distribution partners. This post maps the pullback, why it happened, and how a commercial broker should treat partner runway as a live operational risk in 2026.
By Sarvada Editorial Team
Sarvada Intelligence
See how Sarvada turns research, risk signals, and operational context into faster commercial underwriting decisions.